Apyx Medical Corporation

2.92+0.0500+1.74%Vol 54.09K1Y Perf -54.66%
Mar 24th, 2023 16:00 DELAYED
BID2.70 ASK3.09
Open2.80 Previous Close2.87
Pre-Market- After-Market2.83
 - -  -0.09 -3.08%
Target Price
4.00 
Analyst Rating
Strong Buy 1.00
Potential %
36.99 
Finscreener Ranking
★★★★     53.17
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★     51.33
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     50.07
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
16.35 
Earnings Rating
Strong Sell
Market Cap101.02M 
Earnings Date
11th May 2023
Alpha0.03 Standard Deviation0.21
Beta1.11 

Today's Price Range

2.752.92

52W Range

1.3111.16

5 Year PE Ratio Range

-18.605.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
0.34%
1 Month
1.74%
3 Months
46.73%
6 Months
-39.17%
1 Year
-54.66%
3 Years
-20.44%
5 Years
-2.34%
10 Years
-

TickerPriceChg.Chg.%
APYX2.920.05001.74
AAPL160.251.32000.83
GOOG106.08-0.1850-0.17
MSFT280.572.91001.05
XOM103.530.12000.12
WFC36.23-0.3800-1.04
JNJ152.651.52001.01
FB196.640.99000.51
GE91.37-0.2200-0.24
JPM124.91-1.9300-1.52
 
ProfitabilityValueIndustryS&P 500US Markets
67.80
-38.70
-36.80
-48.90
-53.96
RevenueValueIndustryS&P 500US Markets
31.90M
0.92
20.62
2.71
Earnings HistoryEstimateReportedSurprise %
Q04 2022--0.17-
Q03 2022-0.12-0.17-41.67
Q02 2022-0.20-0.1620.00
Q01 2022-0.13-0.17-30.77
Q04 2021-0.13-0.0653.85
Q03 2021-0.15-0.1220.00
Q02 2021-0.14-0.1214.29
Q01 2021-0.14-0.140.00
Earnings Per EndEstimateRevision %Trend
12/2022 QR-0.14-100.00Negative
12/2022 FY-0.64-23.08Negative
3/2023 QR-0.127.69Positive
12/2023 FY-0.55-27.91Negative
Next Report Date11th May 2023
Estimated EPS Next Report-0.06
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume54.09K
Shares Outstanding34.60K
Shares Float33.31M
Trades Count279
Dollar Volume156.10K
Avg. Volume157.93K
Avg. Weekly Volume62.55K
Avg. Monthly Volume186.62K
Avg. Quarterly Volume224.62K

Apyx Medical Corporation (NASDAQ: APYX) stock closed at 2.92 per share at the end of the most recent trading day (a 1.74% change compared to the prior day closing price) with a volume of 54.09K shares and market capitalization of 101.02M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 266 people. Apyx Medical Corporation CEO is Charles D. Goodwin.

The one-year performance of Apyx Medical Corporation stock is -54.66%, while year-to-date (YTD) performance is 24.79%. APYX stock has a five-year performance of -2.34%. Its 52-week range is between 1.31 and 11.155, which gives APYX stock a 52-week price range ratio of 16.35%

Apyx Medical Corporation currently has a PE ratio of -4.60, a price-to-book (PB) ratio of 2.13, a price-to-sale (PS) ratio of 2.66, a price to cashflow ratio of 133.80, a PEG ratio of 2.32, a ROA of -33.97%, a ROC of -39.34% and a ROE of -43.48%. The company’s profit margin is -53.96%, its EBITDA margin is -36.80%, and its revenue ttm is $31.90 Million , which makes it $0.92 revenue per share.

Of the last four earnings reports from Apyx Medical Corporation, there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.06 for the next earnings report. Apyx Medical Corporation’s next earnings report date is 11th May 2023.

The consensus rating of Wall Street analysts for Apyx Medical Corporation is Strong Buy (1), with a target price of $4, which is +36.99% compared to the current price. The earnings rating for Apyx Medical Corporation stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Apyx Medical Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Apyx Medical Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.17, ATR14 : 0.24, CCI20 : -20.76, Chaikin Money Flow : 0.20, MACD : -0.07, Money Flow Index : 34.43, ROC : -0.68, RSI : 50.66, STOCH (14,3) : 61.11, STOCH RSI : 1.00, UO : 51.86, Williams %R : -38.89), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Apyx Medical Corporation in the last 12-months were: Andrew Makrides (Option Excercise at a value of $76 200), Charles D. Goodwin (Buy at a value of $70 068), Lawrence J. Waldman (Option Excercise at a value of $83 280), Michael Geraghty (Option Excercise at a value of $26 900), Moshe Citronowicz (Option Excercise at a value of $76 200)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Apyx Medical Corporation

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. The company's product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons and cosmetic physicians a unique ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminating unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives majority revenue.

CEO: Charles D. Goodwin

Telephone: +1 727 384-2323

Address: 5115 Ulmerton Road, Clearwater 33760, FL, US

Number of employees: 266

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

53%47%

Bearish Bullish

62%38%

Bearish Bullish

59%41%


News

Stocktwits